Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Triventures is a global venture capital fund founded in 2010, with a primary focus on healthcare and technology sectors. The firm operates from offices in the United States and Israel, initially concentrating on medical devices before expanding its investment strategy to include data-driven solutions and the convergence of health and technology. This evolution reflects a commitment to addressing the complexities of modern healthcare through innovative approaches.
As of now, Triventures manages a diverse portfolio and has established a strong presence in the venture capital landscape. The firm invests at the pre-seed, seed, and Series A stages, targeting early-stage companies that demonstrate validated business models. Triventures emphasizes partnerships with entrepreneurs across various industries, leveraging its strategic locations in the US, Israel, and Canada to enhance its investment reach.
Notable milestones include successful exits from companies such as 1-800 Contacts and Tivity Health, showcasing the firm's ability to identify and support transformative healthcare solutions. Triventures continues to engage actively with industry developments, sharing insights through blog posts and other channels, which further solidifies its reputation in the venture capital community.
Triventures invests in early-stage companies across multiple sectors, including healthcare, biotech, fintech, cybersecurity, and e-commerce. The firm specifically targets pre-seed, seed, and Series A stages, focusing on companies with validated business models that have the potential to transform their respective sectors. This investment strategy is rooted in the belief that bio-convergence and data-driven technologies are key to driving innovation in healthcare and technology.
The firm seeks to partner with entrepreneurs who are not only innovative but also possess a clear vision for their businesses. Triventures emphasizes the importance of a strong founding team and validated market demand as critical factors in its investment decisions. The organization’s geographic focus spans the United States, Israel, and Canada, allowing it to tap into a broad network of resources and expertise.
Triventures is particularly interested in companies that are leveraging technology to improve healthcare outcomes, enhance patient engagement, and streamline operations. The firm’s strategic presence in key markets enables it to identify and support transformative startups that align with its investment thesis.
Triventures has built a diverse portfolio that includes several notable companies, reflecting its focus on transformative healthcare solutions:
This portfolio illustrates Triventures' commitment to investing in companies that are at the forefront of healthcare innovation and technology.
Michal Geva: Managing Partner and Co-Founder, with extensive experience in venture capital and healthcare investments.
Dr. Peter Fitzgerald: Managing Partner and Co-Founder, known for his expertise in medical devices and healthcare innovation.
Dani Goldsher: Partner and CFO, responsible for financial strategy and operations within the firm.
Dr. Martin Leon: Co-Founder, recognized for his contributions to medical technology and innovation.
Dr. Eyal Zimlichman: Chief Innovation Officer at Sheba, bringing a wealth of knowledge in healthcare technology.
Lihi Lubranski: Principal, focusing on sourcing and evaluating investment opportunities.
Ted Tussing: Associate, involved in deal sourcing and due diligence processes.
Karin Bar Or: VP Finance, overseeing financial operations and reporting.
Lidia Verra: Bookkeeper, managing the firm's financial records and transactions.
To pitch to Triventures, founders should use the contact page available at Triventures Contact Page. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team background. Response times may vary, but founders should expect to hear back within a few weeks.
In 2023, Triventures successfully exited from Tivity Health, which focused on wearable neuromodulation therapies for chronic diseases. The firm also saw the acquisition of Medtronic, which developed a single-use intraluminal bypass device.
Triventures has been active in sharing insights through blog posts covering topics such as innovative therapies and partnerships in healthcare. These posts highlight advancements in medical technology and the venture landscape, indicating ongoing engagement with industry developments.
What are Triventures' investment criteria?
Triventures focuses on early-stage companies with validated business models in sectors such as healthcare, biotech, fintech, cybersecurity, and e-commerce. The firm seeks startups that demonstrate the potential to transform their industries through bio-convergence and data-driven technologies.
How can I apply or pitch to Triventures?
Founders can pitch to Triventures through their contact page at Triventures Contact Page. It is advisable to include a detailed business plan and information about the founding team.
What makes Triventures different from other venture capital firms?
Triventures emphasizes a strategic presence in the US, Israel, and Canada, allowing for a broad network of partnerships. The firm focuses on bio-convergence and data-driven technologies, which are critical in modern healthcare innovation.
What is Triventures' geographic scope?
The firm invests globally, with a specific focus on the United States, Israel, and Canada. This geographic diversity enhances its ability to identify and support transformative startups.
What is Triventures' post-investment involvement like?
Triventures actively engages with its portfolio companies, providing mentorship and resources to help them scale. The firm often takes board seats to ensure alignment and support for growth.
What is the typical check size for investments?
Triventures invests at the pre-seed, seed, and Series A stages, although specific check sizes are not disclosed. The firm focuses on early-stage companies with high growth potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.